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Master’s Thesis Abstract
Characterization of the Ubiquitination of ICER, a Potential Anti-Cancer Protein, in
Human Melanoma Cells
Inducible cAMP Early Repressor (ICER) is a transcriptional repressor that regulates the
expression of cAMP inducible genes. ICER has recently garnered attention because of
cAMP’s implication in oncogenesis. ICER is shown to be downregulated in melanomas
by the means of the ubiquitin-proteasome pathway. It is marked for degradation by
ubiquitination on its lysine residues.

By rescuing ICER levels in cancer cells, it is

hypothesized that it may be possible to reverse the adverse progression of melanoma
tumor growth. One possible way of rescuing ICER is by making it unavailable for
ubiquitination by altering its ubiquitination sites. Special mutant ICERs that have their
lysines mutated may offer the answer. Consequently, due to its nature as a transcription
factor, ICER must be localized in the nucleus in order to function properly. Through
immunocytochemistry, Western blotting, luciferase assay, and TUNEL apoptosis
analyses of SK-MEL-24 cancer cell lysine knockout mutants, we were able to show
strong nuclear subcellular localization of our mutant ICERs and efficient binding to
DNA, a requirement for a transcription factor. This could potentially lead to further study
of ICER as a cancer treatment.
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Introduction

Inducible cAMP Early Repressor (ICER) is a very small transcriptional repressor
that regulates the expression of cAMP inducible genes. “ICER” is a general term for
various isoforms ranging in size from 108 to 120 amino acids and resulting from the
CREM (cAMP Responsive Element Modulator) gene. This protein functions as a
homodimer to strongly bind DNA and prevent it from being transcribed, effectively
silencing the genes it regulates. ICER has two specific domains, an N-terminal basic
leucine zipper domain and a C-terminal DNA binding domain. The latter is known to
bind to the cAMP response element, or CRE, which is a canonical DNA sequence,
TGACGTCA, located in cAMP-regulated gene promoters.1

Figure 1. 3D Model of CREB Isoform. A three-dimensional representation of a CREM
gene isoform binding to DNA as a homodimer.2
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ICER is strongly conserved between species that have it which underlies the
importance of its function and has become of interest due to cAMP’s implication in
oncogenesis. Cyclic AMP helps to regulate growth and differentiation of melanocytes, or
melanin producing epidermal cells, which are responsible for the development of human
melanoma. One type of ICER, isoform ICER-I □, has already been shown to be absent
from the nucleus in various cancer cell types, including melanoma. On the other hand,
ICER levels are strongly elevated in cases of degenerating melanoma cells. This leads to
the possibility that ICER may potentially play a role in the destruction of melanoma in
humans.4 In cases of melanoma, ICER is either removed from the nucleus or degraded
via ubiqutination. Since ubiqutination is dependent on ubiquitin being covalently bound
to lysine residues on target proteins, we hypothesize that eliminating ubiqutination sites
may hold the key to rescuing endogenous ICER levels in these cells.5
As a result, recent work has been done to try and establish ICER as a tumor
suppressor protein. This is due to the phenomena in cancer cells where ICER levels are
much lower than that of healthy cells. Rescuing ICER levels in these depleted cancer
cells inhibits growth and negatively impacts the traits that enable cancer cells to grow
uncontrollably such as rampant DNA synthesis and the upregulation of cell cycle related
genes. The pathway through which ICER is degraded in cancer cells has also been
elucidated and is facilitated by the use of the post-translational modifier protein
ubiquitin.6 In cancers, ICER is either monoubiquitinated, which causes it to be
sequestered outside the nucleus rendering it useless, or it is polyubiquitinated, which
causes it to be degraded through the ubiquitination-proteasome pathway.7 In order to be
affected by these two pathways, ICER needs to be able to be phosphorylated and
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ubiquitinated. Phosphorylation marks ICER for ubiquitination and takes place on serine
residues within its primary sequence. It has been shown that in the absence of the serine
residues, ICER levels are higher than when compared to the wildtype. However,
ubiquitination itself takes place on its lysine residues. Potentially, this means that
mutating the various lysine residues of ICER into a chemically similar amino acid, such
as arginine can potentially reduce or eliminate ICER’s ability to be ubiquitinated and
degraded.

o

NH2
Lysine

Arginine

Figure 2. Amino Acids Lysine and Arginine. Both lysine and arginine are polar,
positively charged amino acids and, under usual circumstances, can be substituted for
each other without functional protein consequences being observed.

Melanoma is the sixth most common cancer in the United States.9 The prognosis
for which is very good if the tumor is caught early. However, if the melanoma becomes
metastatic and spreads to other parts of the body before treatment has started, the rate of
survival is dramatically reduced.10 Studies have shown that the oncogenes BRAF and
RAS are responsible for at least 66% of all malignant melanoma cases.11 A mutation in
the BRAF gene, specifically, V600E, contributes to significant upregulation in the
mitogen-activated protein kinase (MAPK) pathway. This is significant because ICER is
3

involved in the MAPK pathway, which, in turn, is involved in cell division and the
development of melanoma. Specifically, when this pathway is down regulated, ICER is
stabilized by cAMP.

Alternatively, a consequence of this pathway activation is the

phosphorylation and ubiquitination of ICER.13 Additionally, forced expression of ICER
results in an inability for cancer cells to grow in an anchorage-independent manner,
resulting in inhibited tumor growth.14 Expression of ICER has been linked to
improvement in other types of cancers, such as leukemia.15 Exclusion of ICER in these
cases may contribute to the symptoms associated with metastatic melanoma. Logically,
this leads to the conclusion that rescuing ICER levels in cancerous cells may lead to
apoptotic death in the affected cells.
The ultimate goal of this study is to determine whether or not various ICER-lysine
mutants would still be degraded via the same pathway or if they would persist and
maintain their original function and location in the nucleus of melanoma cells. If the
mutants do persist, the next step is to investigate the apoptotic effect of ICER on these
cells.
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Materials and Methods

Cell Transfections for lmmunocytochemistry, Western Blot, Luciferase, and TUNEL
SK-MEL-24 cells were purchased (ATCC) and grown using the Nunc Lab-Tek
Chamber slide system (Thermo Scientific) until they were 80% confluent. The cells are
anchorage dependent and adhere to the bottom of the slides. The chambers allowed for
separation of the cells into distinct populations that would be differentiated based on their
respective ICER constructs FuGENE HD Transfection Reagent (Promega) was the
system utilized to transfect the populations. Individual ICER mutant constructs were
diluted to ~1 pg/pL and mixed with the appropriate amount of FuGENE reagent as per
the protocol's recommendation in order to form the transfection complex. Once formed,
the complex was administered to the cells. The total volume of each slide chamber was
brought up to 25 pL using cell media and left to incubate over 48 hours. The protocol for
each transfection was the same with the only variable being the proportions of the
reagents.

lmmunocytochemistry
The cells were grown and transfected as described above. The culture medium
was removed and the cells were washed two times with phosphate buffered saline (PBS)
at room temperature. The cells were fixed by adding ~1 mL 4% formaldehyde in PBS
into the chambers and left for 20 minutes. The formaldehyde was then aspirated and the
cells were washed with PBS three times for 5 minutes each then stored for several days.
Two days later, the antigen retrieval buffer was preheated to 95 degrees Celsius and 1 mL
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of the buffer was added to each chamber and the slides were incubated at 95 degrees
Celsius for 10 minutes. The buffer was aspirated and the cells washed three times with
PBS. The cells were then incubated in 0.1% Triton X-100 in PBS for 15 minutes at room
temperature then washed three times with PBS. All remaining PBS was removed and the
protein block was added and the cells were left to incubate for 1 hour at room
temperature. Phosphate buffer saline was used to wash the cells again and the primary
antibody (polyclonal Rabbit anti-HA at 1 pg/mL in blocking buffer) was applied and cells
left to incubate overnight at 4 degrees Celsius. The next day, the cells were washed four
times with PBS and the secondary antibody (biotinylated Goat anti-Rabbit Polyvalent Abeam) was applied and the cells left to incubate for 10 minutes at room temperature.
The cells were again washed four times with PBS then treated with streptavidin
peroxidase and left to incubate for another 10 minutes at room temperature. The cells
were then washed four more times with PBS then treated with 30 pL of DAB Chromogen
and 1.5 mL of DAB Substrate and swirled. After a final incubation for ~10 minutes and
wash with PBS, a drop of mounting medium was applied and the results observed.

Nuclear and Cytosolic Fractionation
SK-MEL-24 cells were grown in chambers and transfected as described above.
The culture medium was then aspirated and the cells were washed with 2 mL of PBS at
room temperature. Next, the cells were harvested by adding 750 pL of trypsin-EDTA and
incubated at 37 degrees Celsius for three minutes. Then 750 pL/mL of complete cell
culture media was added and gently pipetted up and down to release the cells from the
chamber. The cells were transferred to 1.5 mL microcentrifuge tubes and centrifuged at
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500 x g for 5 minutes. Afterwards, the pellets were suspended with 1 mL of ice-cold PBS
and centrifuged again at 500 x g for 2.5 minutes. The supernatant was discarded and 100
pL of ice-cold Cytosolic Extraction Reagent I (CER I) was added. The tubes were
vortexed on high for 15 seconds to resuspend the pellet and then were incubated on ice
for 10 minutes. Then, 5.5 pL of ice-cold CER II was added to the tubes and the tubes
were vortexed again on high for 5 seconds and put on ice for 1 minute. Next, the tubes
were centrifuged for 5 minutes at -16,000 x g. The supernatant (cytosolic extract) was
transferred to clean, cold tubes and stored at -80 degrees Celsius. The pellet was
resuspended in 50 pL of ice-cold Nuclear Extraction Reagent (NER). The tubes were
then vortexed on high for 15 seconds every 10 minutes for 40 minutes. The tubes were
centrifuged again at -16,000 x g for 10 minutes. The resulting supernatant (nuclear
extract) was transferred to clean, cold tubes and stored at -80 degrees Celsius.

Western Blot and IR Detection
The protein extracts from the previous sections were analyzed via Western blot.
Ten pL of the extracts were pipetted into each lane of two sets of polyacrylamide-SDS
gels and ran at a constant 200 V for 45 minutes. The first set of gels was probed for ICER
while the next set was probed for beta actin as a loading control. The protein on the
resulting gel was transferred onto a nitrocellulose membrane at a constant 100 V for one
hour. Nonspecific antibody protein binding was blocked by incubating the membranes in
blocking buffer for 15 minutes. For the ICER membranes, the primary rabbit anti-HA
antibody was added to a 1 pg/mL solution of blocking buffer and incubated at room
temperature for 6 hours on a swirling platform. The membranes were then washed four
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times for 5 minutes each with PBS containing 0.1% Tween 20 at room temperature. The
secondary goat anti-rabbit antibody was applied in a 1:10,000 dilution in blocking buffer
and the membranes left to incubate at room temperature for 45 minutes. Again, the
membranes were washed four times for 5 minutes each with PBS containing 0.1% Tween
20. The protocol was then repeated for the beta-actin membranes, using anti-beta actin as
the sole antibody. The membranes were then analyzed using near-infrared fluorescence
detection on the Odyssey Imaging System.

Dual Luciferase Reporter Assay
SK-MEL-24 cells were grown in five, twenty-four well dishes in 0.5 mL of media
per dish. Next, 2 mL of 0.25% trypsin was added to each well for incubated for 5 minutes
at 37 degrees Celsius and 8 mL of media was added in addition. The cells were then
transfected as described above. The culture medium was then aspirated and the cells were
washed with PBS and each well treated with 100 pL of passive lysis buffer. The cells
were then rocked gently for 15 minutes at room temperature and lysate was transferred to
new tubes for testing. To activate firefly luciferase, 100 pL of the luciferase assay reagent
II was added to each tube and the luminometer took a reading five seconds later for about
ten seconds each. To activate Renilla luciferase, 100 pL of Stop & Glo reagent (Promega)
was added and measured by luminometer in the same fashion. This was repeated for each
tube.
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Terminal Deoxynucléotidyl Transferase (TdT) dUTP Nick-End Labeling Assay
SK-MEL-24 cells were grown in chambers and transfected as described above.
The culture medium was then aspirated and the cells were fixed in 4% formaldehyde in
PBS for 25 minutes at 4 degrees Celsius. Next, the slides were immersed in PBS twice, 5
minutes each time. The slides were then immersed in 0.2% Triton X-100 in PBS for 5
minutes and washed by immersion twice in PBS, 5 minutes each time. Twenty-five pL of
equilibration buffer was added to the cells at left to incubate at room temperature for 10
minutes. The cells were then labeled using 25 pL of TdT reaction mixture to each
population and covered with a cover slip, then incubated in a humidified chamber at 37
degrees Celsius for 1 hour. Afterwards, the slides were immersed in SSC for fifteen
minutes to stop the reaction. PBS was then used to wash the slides by immersion three
times for 5 minutes each. The cells were counterstained with DAPI and analyzed by
fluorescent microscopy.
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Results

Immunocytochemistry
We utilized immunocytochemistry in order to determine the subcellular
localization of our mutant ICERs. Nuclear localization of ICER is required for the protein
to fulfill its function. The results for the GFP control for each one of the slides shows
very little, if any, ICER signal. Specifically, three out of the five controls showed no
significant signal while the other two show a relatively light and even distribution of
ICER throughout both the nucleus and the cytoplasm (Figures 3-7). When analyzing the
ICER mutants, it is important to note the noticeable difference in the intensity of the
ICER signal when comparing to the controls. Under normal circumstances, ICER would
be either present in the nucleus or presumably ubiquitinated and sequestered to the
cytoplasm. However, almost every ICER mutant shows considerable presence in the
nucleus and cytoplasm with a strong bias towards the nucleus.
The mutants located in the N-terminal domain, KO-52 through K0-70 (Figure 4),
of the protein may have less of a dramatic effect on ICER binding and ubiquitination.
These cells show an ICER signal more prominently than the control but not as much as
the mutants located in the DNA binding domain. KO-76 through KO-97 (Figures 5-6),
which happen to be located in the DNA binding domain of ICER, have the highest
nuclear to cytosolic ratio in terms of signal out of the mutants tested, even more so than
the complete KO mutants. Interesting though, the HA tagged wildtype cells show a
convincingly even distribution of ICER throughout. The wildtype cells would be
expected to more closely resemble the controls than the mutants.
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Control-GFP (C) 20x

NHA-wt (Nwt) 20x

CHAnoLys (CKO) 20x

CHA-wt (Cwt) 20x

Figure 3. Micrographs of the Control, Nwt, CKO, and Cwt. The GFP control is
showing a neutral, blank signal throughout all the cells in the field of view. CKO, which
has an HA tag on the C terminus, shows a strong nuclear signal which may indicate the
significance of the C terminus in ICER localization. The wildtypes show a strong signal
but do not show specific ICER localization.
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Control-GFP (C) 20x

NHAnoLys-59 (59) 20x

NHAnoLys-52 (52) 20x

NHAnoLys-70 (70) 20x

Figure 4. Micrographs of the Control, KO-52, KO-59, and K0-70. These mutants are
located most closely to the N terminus of ICER. We hypothesize that they may have
decreased significance in the ubiquitination process due to their location. However, the
strong ICER localization in the nucleus should be noted.
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Control-GFP (C) 20x

NHAnoLys-72 (72) 20x

NHAnoLys-71 (71) 20x

NHAnoLys-76 (76) 20x

Figure 5. Micrographs of the Control, KO-71, KO-72, and KO-76. This control is one
of the few exceptions where there is a noticeable ICER signal and it is only seen in the
nucleus. As the position of the lysines approach the DNA binding domain, it becomes
more apparent that their ICER localization is more strongly nuclear than otherwise. This
would be consistent with the idea that the residues susceptible to ubiquitination in this
domain are more relevant in ICER processing.
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NHAnoLys-97 (97) 20x
Figure 6. Micrographs of the Control, KO-87, K0-90, and KO-97. As the mutated
residues approach the C terminal end, the effect on ICER localization is consistent with
the previous cells in Figure 5. ICER is predominantly in the nucleus when it would
otherwise not be, as seen in the control.
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Control-GFP (C) 20x

NHAnoLys-106 (106) 20x

NHAnoLys-100(100) 20x

NHAnoLys (NKO) 20x

Figure 7. Micrographs of the Control, K0-100, K0-106, and NKO. K0-100 and K0106 most closely resemble the previous mutants with nearby lysine mutations. Of note,
the NKO mutant can be compared to both the wildtype populations seen previously. The
ICER distribution here is strong and even distributed throughout the cells.
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Western Blot Analysis
In an effort to provide evidence in support of the immunocytochemistry results,
Western blots were performed to qualitatively corroborate the significant nuclear
localization bias of our mutant ICERs. It was expected that the controls, CKO and NKO,
would have the strongest ICER signal in the nucleus compared to the control and the
wildtypes. The results show they do appear to have the strongest ICER expression
indicated by the intensity of their bands, the complete knockouts also have the highest
concentration of ICER in the nucleus when compared to the other mutants but not the
wildtypes (Figure 8A). The evidence also confirms the presence of degraded forms of
ICER in the complete knockouts, which is shown by the less intense bands further south
on the gel. Concentrations of these degraded proteins are similar to that of the Cwt.
Interestingly, KO-59 has no ICER signal in either extract. This is inconsistent with
earlier findings from the immunocytochemistry that showed a distributed pattern between
the two. There is no instance where ICER is completely either in the nucleus or the
cytosol. The extent of the difference between the signals is what is significant here. K090 and KO-97 are clear examples of the mutants ICERs showing strong nuclear
localization. Overall, the bands representing the cytosolic ICER in the mutants are
definitively less intense than the wildtype and the bands representing the nuclear ICER
are diminished as well but contain a larger proportion of the overall distribution. This
supports the hypothesis that the mutants ICERS remain in the nucleus for longer periods
of time when compared to the wildtype.
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Figure 8. Nuclear and Cytosolic Western Blots of ICER Mutants. A) The majority of
the mutant ICERs have strong nuclear (N):cytosolic(C) ratios. Intensity of the bands
representing the nucleus appears to be either as strong as or stronger than the cytosolic
bands. B) The beta-actin bands are loading controls and show consistent protein
concentration between samples.
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Dual Luciferase Reporter Assay
Perhaps more important than the location of ICER is the efficiency at which it
binds to DNA and represses gene expression. The ratio of luminescence in this assay is
the indicator of the efficiency of each of the mutant ICERs. If the ratio is high, ICER is
repressing less. If the ratio is lower, ICER is repressing more strongly. The data (Figure
9) indicates that the mutant ICERs are repressing genes more strongly than their wildtype
counterparts. The wildtype cells had an average ratio of luminescence of about 0.07 while
every mutant tested was less than 0.02. This is a significant difference in efficiency that
may be attributed to the inability of the cells to remove ICER from the nucleus. The
previous data support the assertion that the levels of ICER are elevated in the nucleus of
these mutants and the luciferase assay seems to suggest that they are more efficient in
their role as a repressor.
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Figure 9. Dual Luciferase Assay Graphical Representation. The data show a
significant difference between wildtype ICER efficiency versus the mutants.
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Terminal Deoxynucleotidyl Transferase (TdT) dUTP Nick-End Labeling Assay
The goal of the TUNEL assay is to show levels of apoptosis in a given cell
population. Specifically, we are interested in determining if there is a connection between
rescuing ICER levels and increased apoptosis in melanoma cells. The data presented for
the TUNEL assay (Figures 10-13) are preliminary and do not currently support our
hypothesis that stronger nuclear localization of ICER may increase levels of apoptosis in
melanoma cells. A positive result for apoptosis would look similar to what is seen in the
control micrograph utilizing DNase I (Figure 10). The coloration is obvious and easy to
see. However, looking at the micrographs for the mutants, it would seem as if there is a
negligible effect on the viability of the cells. Out of the hundreds of cells visible using
DAPI stain, there is no significant data for most mutants. On the other hand, KO-76 and
KO-87 (Figure 12) have an appreciable signal compared to the rest. Though the signal is
not as strongly represented in the micrographs as it is in the control, the light green glow
may indicate the process of apoptosis on some diminished level. This may be evidence
for further investigating the DNA binding domain. There are only few instances where
the bright green intensity of the control was seen in the mutant populations. For example,
KO-71 and KO-76 (Figures 11-12) have nine and three spots of significance, respectively.
The mutant ICERs’ effect on apoptosis requires further research.
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Control-DNase I (C) DAPI 20x

Control-DNase I (C) TUNEL 20x

NHA-wt (Nwt) DAPI 20x

NHA-wt (Nwt) TUNEL 20x

CHA-wt (Cwt) DAPI 20x

CHA-wt (Cwt) TUNEL 20x

pCMV Renilla DAPI 20x

pCMV Renilla TUNEL 20x

Figure 10. TUNEL Micrographs of the Control, Nwt, Cwt, and pCMV Renilla.

NHAnoLys-52 (52) DAPI 20x

NHAnoLys-52 (52) TUNEL 20x

NHAnoLys-59 (59) DAPI 20x

NHAnoLys-59 (59) TUNEL 20x

NHAnoLys-70 (70) DAPI 20x

NHAnoLys-70 (70) TUNEL 20x

NHAnoLys-71 (71) DAPI 20x

NHAnoLys-71 (71) TUNEL 20x

Figure 11. TUNEL Micrographs of KO-52, KO-59, K0-70, and KO-71.
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NHAnoLys-76 (76) DAPI 20x

NHAnoLys-76 (76) TUNEL 20x

NHAnoLys-87 (87) DAPI 20x

NHAnoLys-87 (87) TUNEL 20x

NHAnoLys-90 (90) DAPI 20x

NHAnoLys-90 (90) TUNEL 20x

NHAnoLys-97 (97) DAPI 20x

NHAnoLys-97 (97) TUNEL 20x

Figure 12. TUNEL Micrographs of KO-76, KO-87, K0-90, and KO-97.

NHAnoLys-100 (100) DAPI 20x

NHAnoLys-100 (100) TUNEL 20x

NHAnoLys-106 (106) DAPI 20x

NHAnoLys-106 (106) TUNEL 20x

NHAnoLys (NKO) DAPI 20x

NHAnoLys (NKO) TUNEL 20x

Figure 13. TUNEL Micrographs of K0-100, K0-106, and NKO.

Discussion

ICER Lysine Mutants are Strongly Localized to the Nucleus o f SK-MEL-24 Cells
Due to its nature as a transcription factor, it is imperative that ICER remains in the
nucleus of cells in order to provide for its function. Since it has been shown numerous
times that ICER is marked for ubiquitin-mediated degradation and ICER levels are either
extremely diminished or absent altogether in cancer cells, we have hypothesized that
rescuing this protein may have a lethal effect on these cells. We have shown that
combatting the expulsion of ICER from the nucleus by altering the sites at which it is
marked for destruction is a viable first step in a path to potentially taking this research a
step further and developing an ICER based cancer treatment.
Our results for immunocytochemistry are convincing enough to conclude that our
ICER mutants are resisting ubiquitination. It is interesting that in the majority of
conditions, there always seems to be a small amount of ICER in the cytoplasm regardless
of the levels in the nucleus. This is indicated by the pinkish signal seen in all the mutants
and even the controls. The evidence still strongly points toward the DNA binding domain
of ICER being the area of most promise. For example, KO-87 and KO-97 (Figure 6) have
the largest ratio of nuclear to cytosolic ICER. There is almost no signal originating in the
cytosol. Future research in this area, specifically in this domain, may further elucidate the
mechanisms involved. Unexpectedly, the NKO and the CKO (Figures 3 and 7) cells have
ICER in their cytosol. These cells are complete lysine knockouts and if ICER degradation
based

on

ubiquitination

of

the

lysine

residues

was

the
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only mode of protein tagging taking place, it is unlikely there would be much, if any,
ICER present in the cytoplasm. This seems to suggest that some other mechanism is
either occurring simultaneously and compensating for the diminished efficiency of
ubiquitination. Many such mechanisms do exist in nature and work in ways similar to
ubiquitination.16 Examples of two such mechanisms are sumoylation and neddylation.17"18
These processes utilizing the proteins SUMO and NEDD8, respectively, are in a class
called “ubiquitin-like proteins” and also modify cellular proteins post-translation, even
for destruction, similarly to ubiquitination.19 It is possible that these mechanisms, or the
others that exist, may have contributed to the unexplained levels of ICER in the cytosol.

Western Blot Analysis Confirms Higher ICER Concentration in the Nucleus than Cytosol
The results from the Western blots are consistent with the conclusions illustrated
from the immunocytochemistry. Supporting prior evidence, the results show a clear ICER
localization to the nucleus. When considering previous work that has shown the absence
of ICER in the nucleus of cancer cells, it is interesting to note the nucleus heavy bias in
ICER concentration.20 Most of the mutant ICERs tested had nuclear:cytosolic ratios on
par with that of the control or a more intense ratio favoring the nucleus (Figure 8). This
provides further evidence to suggest that altering the lysine residues on the protein make
it more difficult for the cellular machinery to degrade ICER. Due to beta-actin’s nature as
a cytosolic protein, its strong presence in the nucleus seems to indicate cross
contamination between the cellular fractions; although under specific cellular conditions,
beta actin may be present in the nucleus.21 If this were the case, ICER concentration in
the nucleus may be more diluted in our results than what they actually are. In terms of the
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application of this information, ICER has already been shown to reverse tumor growth in
rat prostate cancer.22 Establishing the nuclear localization of ICER in human melanoma
cells is the first step on the way to testing the proteins effect on the viability of the cells
and hopefully showing that ICER can cause apoptosis in these cells.

ICER Mutants Repress More Strongly than Wildtype ICER
ICER localization in the nucleus is not enough for the mutants to outperform the
wildtype. In order for this to occur, the mutants must bind with their canonical CRE
sequence in similar or greater levels. If the mutants were mainly located in the nucleus
but did not bind to DNA efficiently, their presence would be redundant. The dual
luciferase assay exhibits the strong repressing power of our mutant ICERs. The controls
for this experiment indicated by the large bars (Figure 9) show what would be considered
wildtype levels of ICER efficiency in cells that are already known to be ICER-deficient.
The data for the mutants support the assertion that the mutants ICERs are much better at
repressing genes that are transcriptionally affected by ICER. The ratio between firefly
luciferase:Renilla luciferase is large and provides evidence for strong repression and
results in the small bars in comparison to the wildtype controls. The conclusion drawn
from this experiment is that the ICER mutants are much better repressors than the
wildtype ICER.
As the TUNEL data presented here are preliminary (Figures 10-13), they do not
currently paint a picture supporting the hypothesis that mutant ICERs will cause
apoptosis in human melanoma cells on their own. A positive, apoptotic result would have
shown a vast number of bright green cells in relation to the total number of cells present
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indicated by the DAPI stain. The current data show no real correlation between increased
mutant ICER localization in the nucleus and the viability of the cells. The lack of any
appreciable results from this experiment suggests either a scientific dead end or human
error resulting in misleading data. In either case, more research is needed to further
investigate the potential link between our mutant ICERs and apoptosis in cancer cells.
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